Fundraising Fox
🦊/Companies
Sign in

GVB Biopharma

Las Vegas, US · Founded 2019 · Nevada corporation

Find your way into GVB Biopharma

GVB Biopharma is a manufacturer of cannabidiol (CBD) products, handling farming, CBD extraction, and scaled production. The company serves the legal cannabinoid and pharmaceutical ingredient market.

Advanced ManufacturingBiotechConsumerWellness & Fitness

Founders & leadership

GVB Biopharma was founded in 2019 by Drew Spiegel.

DSDrew Spiegel
Drew SpiegelinCEO & Co-Founder
SRSebastian Ravitz
Sebastian RavitzinChief Marketing Officer
JMJoe Maher
Joe MaherinChief Financial Officer
TS
Theodore SwindellsNamed on SEC filing
PS
Phillip SwindellsCOO & Co-Founder
WS
William SpiegelNamed on SEC filing
JF
Jack FeldmanPresident & Co-Founder

Reported raises · per SEC filings

Form D private placements

$13.6M disclosed across 6 rounds · 2020–2022

▶$1MraisedMay 2022 · 1 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Theodore SwindellsDirector
  • William SpiegelExecutive Officer, Director
  • Jack FeldmanExecutive Officer, Director
  • Phillip SwindellsExecutive Officer, Director
Offering amount
$1M
Amount sold
$1M
Minimum investment
$50K
Sales commissions
$100K
Placement agents
TerraNova Capital Equities, Inc.
First sale
Apr 2022
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedJan 2022 · 2 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • William SpiegelExecutive Officer, Director
  • Theodore SwindellsDirector
  • Phillip SwindellsExecutive Officer, Director
  • Jack FeldmanExecutive Officer, Director
Offering amount
$1.8M
Amount sold
$1.8M
Minimum investment
$50K
Sales commissions
$25K
Placement agents
TerraNova Capital Equities, Inc.
First sale
Jan 2022
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedNov 2021 · 10 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • William SpiegelExecutive Officer, Director
  • Phillip SwindellsExecutive Officer, Director
  • Theodore SwindellsDirector
  • Jack FeldmanExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$1.5M
Minimum investment
$25K
Sales commissions
$100K
Placement agents
TerraNova Capital Equities, Inc.
First sale
Oct 2021
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.6MraisedNov 2020 · 28 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Theodore SwindellsDirector
  • William SpiegelExecutive Officer, Director
  • Jack FeldmanExecutive Officer, Director
  • Phillip SwindellsExecutive Officer, Director
Offering amount
$8M
Amount sold
$7.6M
Minimum investment
$500K
Sales commissions
$640K
Placement agents
M.S. Howells & Co., TerraNova Capital Equities, Inc.
First sale
Nov 2020
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedMay 2020 · 1 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • William SpiegelExecutive Officer, Director
  • Jack FeldmanExecutive Officer, Director
  • Phillip SwindellsExecutive Officer, Director
  • Theodore SwindellsDirector
Offering amount
$3M
Amount sold
$1.3M
Minimum investment
$50K
Sales commissions
$300K
Placement agents
TerraNova Capital Equities, Inc.
First sale
May 2020
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$450KraisedApr 2020 · 4 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Theodore SwindellsDirector
  • Phillip SwindellsExecutive Officer, Director
  • William SpiegelExecutive Officer, Director
  • Jack FeldmanExecutive Officer, Director
Offering amount
$2M
Amount sold
$450K
Minimum investment
$50K
Sales commissions
$200K
Placement agents
TerraNova Capital Equities, Inc.
First sale
Feb 2020
Incorporated
Corporation, Nevada, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Leafwell513 shared keywordsLeafwell provides personalized cannabis therapy recommendations and virtual specialty care for patients seeking treatment for various health conditions, leveraging real-world data and machine learning to optimize cannabinoid-based treatment plans.
Leafly499 shared keywordsLeafly operates an online marketplace and information resource for cannabis, letting consumers research strains and products and order from licensed retailers, while offering customer-acquisition tools to cannabis brands and retailers. It also publishes cannabis journalism and educational resources for a worldwide consumer audience.

Companies competing with GVB Biopharma for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does GVB Biopharma do?
GVB Biopharma is a manufacturer of cannabidiol (CBD) products, handling farming, CBD extraction, and scaled production. The company serves the legal cannabinoid and pharmaceutical ingredient market.
Who founded GVB Biopharma?
GVB Biopharma was founded by Drew Spiegel in 2019.
How much funding has GVB Biopharma raised?
GVB Biopharma has disclosed $13.6M raised across 6 rounds.
Where is GVB Biopharma headquartered?
GVB Biopharma is headquartered in Las Vegas, US.